True precision medicine through single-cell science.
Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles. The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality.
If you want to partner with, reach out to contact@scailyte.com
More information about our company, technology & services you can find on our website - https://scailyte.com
Company Details
- Employees
- 21
- Founded
- -
- Address
- Lichtstrasse 35,
- co****@****yte.com
- Industry
- Biotechnology
- Website
- scailyte.com
- Keywords
- artificial intelligence, diagnostics, single-cell, medtech, biomarker, big data, clinical research, data analysis, software, cytometry.
- HQ
- Basel
Scailyte Questions
Scailyte's website is scailyte.com
Scailyte's LinkedIn profile is https://www.linkedin.com/company/scailyte
Scailyte has
21 employees.
View email and phone details for 21
employees at Scailyte.
Scailyte's industry is
Biotechnology
Scailyte's top competitors are
Cradle,
Nerai Bioscience,
Malaica,
Nagi Bioscience,
Sophia Genetics,
Alp Ai,
Insphero,
Haya Therapeutics,
Hedera Dx,
Juvion Health Sciences.
Scailyte's support email address is contact@scailyte.com
Scailyte's categories are Biotechnology
Scailyte's founding year is 2017
